Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 365

Showing 1-25 of 365 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 655
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms
Anders Wanhainen, Isabelle Van Herzeele, Frederico Bastos Gonçalves, et al.
European Journal of Vascular and Endovascular Surgery (2024) Vol. 67, Iss. 2, pp. 192-331
Open Access | Times Cited: 296
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
Nikolaus Marx, Mansoor Husain, Michael Lehrke, et al.
Circulation (2022) Vol. 146, Iss. 24, pp. 1882-1894
Open Access | Times Cited: 207
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Josef Coresh, Michael Pencina, et al.
Circulation (2023) Vol. 148, Iss. 24, pp. 1982-2004
Closed Access | Times Cited: 167
Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention
Nathan D. Wong, Naveed Sattar
Nature Reviews Cardiology (2023) Vol. 20, Iss. 10, pp. 685-695
Closed Access | Times Cited: 161
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication
Joakim Nordanstig, Christian‐Alexander Behrendt, Iris Baumgärtner, et al.
European Journal of Vascular and Endovascular Surgery (2023) Vol. 67, Iss. 1, pp. 9-96
Open Access | Times Cited: 126
Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
Piotr Dobrowolski, Aleksander Prejbisz, Alina Kuryłowicz, et al.
Archives of Medical Science (2022) Vol. 18, Iss. 5, pp. 1133-1156
Open Access | Times Cited: 125
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Leopoldo Pérez de Isla, José Luis Díaz-Díaz, Manuel Romero, et al.
Circulation (2023) Vol. 147, Iss. 19, pp. 1436-1443
Open Access | Times Cited: 51
Update on obesity, the obesity paradox, and obesity management in heart failure
Pamela L. Alebna, Anurag Mehta, Amin Yehya, et al.
Progress in Cardiovascular Diseases (2024) Vol. 82, pp. 34-42
Closed Access | Times Cited: 36
The impact of population ageing on the burden of chronic kidney disease
Nicholas C. Chesnaye, Alberto Órtiz, Carmine Zoccali, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 569-585
Closed Access | Times Cited: 28
Life course epidemiology and public health
Cornelia Wagner, Cristian Carmeli, Josephine Jackisch, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 4, pp. e261-e269
Open Access | Times Cited: 25
Cutting-edge lipid-lowering pharmacological therapies: Improving lipid control beyond statins
Maurizio Capuozzo, Alessandro Ottaiano, Claudia Cinque, et al.
Hipertensión y Riesgo Vascular (2025)
Closed Access | Times Cited: 1
A Symbolic AI Approach to Medical Training
Alessio Bottrighi, Federica Grosso, Marco Ghiglione, et al.
Journal of Medical Systems (2025) Vol. 49, Iss. 1
Open Access | Times Cited: 1
Cardiovascular risk profiling among South Asian adults in Hong Kong: a latent class analysis
Gary Ka-Ki Chung, Woohyung Lee, Danna Camille Vargas, et al.
International Journal for Equity in Health (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study
Mathias Ausserwinkler, Sophie Gensluckner, Vanessa Frey, et al.
Rheumatology International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 1
The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis
Jiedong Ma, Hongqi Zhang, Yufei Chen, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1702-1702
Open Access | Times Cited: 53
Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
Anna Martin, Sonja Lang, Tobias Goeser, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 533-546
Open Access | Times Cited: 46
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
Christie M. Ballantyne, Marc Ditmarsch, John J.P. Kastelein, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 4, pp. 491-503
Open Access | Times Cited: 39
Cardiorenal benefits of finerenone: protecting kidney and heart
José Ramón González‐Juanatey, José Luis Górriz, Alberto Órtiz, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 502-513
Open Access | Times Cited: 31
Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
Maria C. Castelijns, Marga A. G. Helmink, Steven H J Hageman, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e066952-e066952
Open Access | Times Cited: 28
Effectiveness of nurse-led interventions versus usual care to manage hypertension and lifestyle behaviour: a systematic review and meta-analysis
Lemma N Bulto, Jacqueline Roseleur, Sara Noonan, et al.
European Journal of Cardiovascular Nursing (2023) Vol. 23, Iss. 1, pp. 21-32
Open Access | Times Cited: 23
Cognitive-behavioural therapy reduces psychological distress in younger patients with cardiac disease: a randomized trial
Annette Holdgaard, Christine Eckhardt-Hansen, Christina Funch Lassen, et al.
European Heart Journal (2023) Vol. 44, Iss. 11, pp. 986-996
Open Access | Times Cited: 22
Fish and Seafood Safety: Human Exposure to Toxic Metals from the Aquatic Environment and Fish in Central Asia
Gulnur Zhuzzhassarova, Faranak Azarbayjani, Galia Zamaratskaia
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1590-1590
Open Access | Times Cited: 9
Comprehensive and personalized approach is a critical area for developing remote cardiac rehabilitation programs
Garyfallia Pepera, Varsamo Antoniou, Jing Jing Su, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 12, pp. 2009-2015
Open Access | Times Cited: 8
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Luis Carlos Saiz, Javier Gorricho, Javier Garjón, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top